Thrombosis and Haemostasis, Table of Contents Thromb Haemost 2005; 93(01): 63-69DOI: 10.1160/TH04-06-0345 Blood Coagulation, Fibrinolysis and Cellular Haemostasis Schattauer GmbH Treatment of 51 pregnancies with danaparoid because of heparin intolerance Edelgard Lindhoff-Last 1 Division of Vascular Medicine, Department of Internal Medicine, University Hospital Frankfurt, Germany , Hans-Joachim Kreutzenbeck 2 Medical Department, Celltech, Essen, Germany , Harry N. Magnani 3 Clinical Consultant Marketing, Organon BV, Oss, The Netherlands › Author Affiliations Recommend Article Abstract Full Text PDF Download Keywords KeywordsPregnancy - heparin-induced thrombocytopenia - heparin-induced - skin rash - danaparoid - heparin-intolerance References References 1 Magnani HN. Heparin-induced thrombocytopenia (HIT): an overview of 230 patients treated with Orgaran (Org 10172). Thromb Haemost 1993; 70: 554-61. 2 Magnani HN. Orgaran® (danaparoid) use in the syndrome of heparin-induced thrombocytopenia. Platelets 1997; 8: 74-81. 3 Chong BH, Castaldi PA. Heparin-induced thrombocytopenia: further studies of the effects of heparindependent antibodies on platelets. Br J Haematol 1986; 64: 347-54. 4 Greinacher A, Michels I, Kiefel V. et al A rapid and sensitive test for diagnosing heparin-associated thrombocytopenia. Thromb Haemost 1991; 66: 734-6. 5 Amiral J, Bridey F, Wolf M. et al Antibodies to macromolecular platelet factor 4-heparin complexes in heparin-induced thrombocytopenia. Thromb Haemost 1995; 73: 21-8. 6 Sheridan D, Carter C, Kelton JG. A diagnostic test for heparin-induced thrombocytopenia. Blood 1986; 67/1: 27-30. 7 Teien AN, Lie M. Evaluation of an amidolytic heparin assay method: increased sensitivity by adding purified antithrombin III. Thromb Res 1977; 21: 169-73. 8 Boshkov LH, Hamilton P, Lee A. et al Successful therapy of heparin-induced thrombocytopenia with thrombosis (HITTS) in pregnancy with danaparoid sodium. Blood 1999; 94 (Suppl. 01) 102b. 9 Gerhardt A, Zotz RB, Scharf RE. Successful use of danaparoid in pregnant women with valve prosthesis and heparin-induced thrombocytopenia Type II (HIT type II). Haemostaseology 2004; 24: A77 Abstract P151. 10 Gill J, Kovacs MJ. Successful use of danaparoid in treatment of heparin-induced thrombocytopenia during twin pregnancy. Obstet Gynecol 1997; 90: 648-50. 11 Grainger JD, Hay CRM. Heparin induced thrombocytopenia caused by danaparoid sodium. Thromb Haemost 2001; 86 suppl Abstract 3458. 12 Harrison SJ, Rafferty I, McColl MD. Management of heparin allergy during pregnancy with danaparoid. Blood Coagul Fibrinolysis 2001; 12: 157-9. 13 Horellou MH, Elalamy I, Achkar A. et al Efficacy and safety of danaparoid (Orgaran® ) in venous thrombosis in pregnant women with thrombophilia and heparin- induced thrombocytopenia. Thromb Haemost 2001; 86 suppl Abstract 2997. 14 Macchi L, Sarfati R, Guicheteau M. et al Thromboembolic prophylaxis with danaparoid (Orgaran® ) in a high thrombosis risk pregnant woman with a history of heparin-induced thrombocytopenia (HIT) and Widal’s disease. Clin Appl Thromb Haemost 2000; 6: 187-9. 15 Rondeau M, Weber JC, Haffner C. et al HELLP syndrome, catastrophic antiphospholipid syndrome or heparin-induced thrombocytopenia?. J Autoimmun 2000; 15: A68. 16 Saint-Blanquat L de, Simon L, Toubas MF. et al Traitement par le danaparoide de sodium au cours de la grossesse chez une patiente présentant une allergie cutanée aux héparines de bas poids moleculaire. Ann Fr Anesth Reanim 2000; 19: 751-4. 17 Taylor AA. Successful use of heparinoids in a pregnancy complicated by allergy to heparin. BJOG 2001; 108: 1011-2. 18 Wilhelm MJ, Schmid C, Kececioglu D. et al Cardiopulmonary bypass in patients with heparin-induced thrombocytopenia using Org 10172. Ann Thorac Surg 1996; 61: 920-4. 19 Woo Yl, Allard S, Cohen H. et al Danaparoid prophylaxis in pregnant women with heparin-induced thrombocytopenia. BJOG 2002; 109: 466-8. 20 Henny ChP, ten Cate H, ten Cate JW. et al Thrombosis prophylaxis in an AT III deficient pregnant woman: application of a low molecular weight heparinoid. Thromb Haemost 1986; 55: 301. 21 Besien K van, Hoffman R, Golichowski A. Pregnancy associated with lupus anticoagulant and heparininduced thrombocytopenia: management with a low molecular weight heparinoid. Thromb Res 1991; 62: 23-9. 22 Greinacher A, Eckhardt Th, Mussmann J. et al Pregnancy complicated by heparin-associated thrombocytopenia: management by a prospectively in-vitro selected heparinoid (Org 10172). Thromb Res 1993; 71: 123-6. 23 Porzelt C, Drummer B, Hoffmann A. Thromboprophylaxe in der Schwangerschaft nach Polytraumatisiering mit Splenektomie und Immobilisation bei heparininduzierter "relativer" Thrombozytopenie Typ II. Geburtsh Frauenheilk 2002; 62: 784-6. 24 Schindewolf M, Mosch G, Bauersachs RM. et al Safe anticoagulation with danaparoid in pregnancy and lactation. Thromb Haemost 2004; 92 (01) 211. 25 Gould J, Meyers B. Prophylactic danaparoid in heparin- induced thrombocytopenia presenting with skin manifestations in pregnancy. Blood Coagul Fibrinolysis 2002; 13/8: A18. 26 Deschamps A, Mathelier-Fusade P, Bernaille JL. Réaction cutanée a l’héparine pendant la grossesse: à propos d’un cas traité avec succès par le danaparoïde. Rev Française Allergol Immunol Clin 2003; 43: 131-4. 27 Horellou MH, Conard J, Achkar A. et al Treatment of thrombosis with low molecular weight heparins during 15 pregnancies in 14 women. Thromb Haemost 1997; 77 Suppl 733 Abstract 2992. 28 Lemesle FG, Mebroukine L, Ermacora P. et al Thrombose, thrombopénie sous HBPM et délivrance. La Presse Médicale 1998; 27: 19. 29 Herzog S, Rath W, Kuhn W. Successful therapy of a heparin-induced thrombocytopenia with a lowsulphated heparinoid. Geburtsh u Frauenheilk 1995; 55: 164-6. 30 Fausett MB, Vogtlander M, Lee RM. et al Heparin- induced thrombocytopenia is rare in pregnancy. Am J Obstet Gynecol 2001; 185: 148-52. 31 Peeters LLH, Vogel GMT, Hasenack HG. et al Placental transfer of Org 10172 a low molecular weight heparinoid in the awake late pregnant guinea pig. Thromb Res 1986; 44: 277-83. 32 Warkentin TE, Chong BH, Greinacher A. Heparininduced thrombocytopenia: Towards consensus. Thromb Haemost 1998; 79: 1-7. 33 Warkentin TE. Heparin-induced thrombocytopenia: pathogenesis and management. Br J Haematol 2003; 121: 535-55. 34 Greinacher A, Alban S. Heparinoide als eine Alternative für die parenterale Antikoagulation bei Patienten mit Heparin-induzierten Thrombozytopenie. Hämostaseologie 1996; 16: 41-9. 35 Grassegger A, Fritsch P, Reider N. Delayed-type Hypersensitivity and Cross-reactivity to heparins and heparinoids: a prospective study. Dermatol Surg 2001; 27: 47-52. 36 Harenberg J, Huhle G, Wang L. et al Association of heparin-induced skin lesions, intra-cutaneous tests and heparin-induced IgG. Allergy 1999; 54: 473-7. 37 Koch P Müßinger, Rupp-John C. et al Delayedtype hypersensitivity skin reactions caused by subcutaneous unfractionated and low molecular weight heparins: tolerance of a new recombinant hirudin. J Am Acad Dermatol 2000; 42: 612-9. 38 Boehncke WH, Weber L, Gall H. Toleranz gegenüber intravenöser Applikation von Heparin und Heparinoid bei einer Patientin mit Typ-IV Allergie auf Heparine und Heparinoide. Allergologie 1996; 19: 95. 39 Figarella I, Barbaud A, Lecompte T. et al Réaction cutanée d’hypersensibilité retardée avec polsensibilisation aux héparines et héparinoides. Ann Dermatol Venereol 2001; 128: 25-30. 40 Enso MHH, Stephenson MD. Low molecular weight heparins in pregnancy. Pharmacotherapy 1999; 19: 1013-25.
